Tools
Tools
Vinciguerra, M, Olier, I, Ortega-Martorell, S and Lip, GYH (2022) New use for an old drug: Metformin and atrial fibrillation. Cell reports. Medicine, 3 (12). ISSN 2666-3791
|
Text
PIIS2666379122004396.pdf - Published Version Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (203kB) | Preview |
Publisher URL: http://dx.doi.org/10.1016/j.xcrm.2022.100875
Open Access URL: http://dx.doi.org/10.1016/j.xcrm.2022.100875
(published)
Abstract
Lal and colleagues1 reported an integrative approach-combining transcriptomics, iPSCs, and epidemiological evidence-to identify and repurpose metformin, a main first-line medication for the treatment of type 2 diabetes, as an effective risk reducer for atrial fibrillation.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | Humans; Atrial Fibrillation; Diabetes Mellitus, Type 2; Metformin; Humans; Metformin; Atrial Fibrillation; Diabetes Mellitus, Type 2 |
| Subjects: | Q Science > QA Mathematics > QA75 Electronic computers. Computer science R Medicine > R Medicine (General) R Medicine > RC Internal medicine R Medicine > RS Pharmacy and materia medica |
| Divisions: | Computer Science & Mathematics |
| Publisher: | Elsevier BV |
| SWORD Depositor: | A Symplectic |
| Date Deposited: | 03 Jan 2023 11:28 |
| Last Modified: | 03 Jan 2023 11:30 |
| DOI or ID number: | 10.1016/j.xcrm.2022.100875 |
| URI: | https://researchonline.ljmu.ac.uk/id/eprint/18516 |
 |
View Item |